These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 24961373)

  • 1. OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin.
    Chen L; Shu Y; Liang X; Chen EC; Yee SW; Zur AA; Li S; Xu L; Keshari KR; Lin MJ; Chien HC; Zhang Y; Morrissey KM; Liu J; Ostrem J; Younger NS; Kurhanewicz J; Shokat KM; Ashrafi K; Giacomini KM
    Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9983-8. PubMed ID: 24961373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organic cation transporter 1 (OCT1) modulates multiple cardiometabolic traits through effects on hepatic thiamine content.
    Liang X; Yee SW; Chien HC; Chen EC; Luo Q; Zou L; Piao M; Mifune A; Chen L; Calvert ME; King S; Norheim F; Abad J; Krauss RM; Giacomini KM
    PLoS Biol; 2018 Apr; 16(4):e2002907. PubMed ID: 29659562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Metformin and Thiamine Uptake between Human and Mouse Organic Cation Transporter 1: Structural Determinants and Potential Consequences for Intrahepatic Concentrations.
    Meyer MJ; Tuerkova A; Römer S; Wenzel C; Seitz T; Gaedcke J; Oswald S; Brockmöller J; Zdrazil B; Tzvetkov MV
    Drug Metab Dispos; 2020 Dec; 48(12):1380-1392. PubMed ID: 33037045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.
    Shu Y; Sheardown SA; Brown C; Owen RP; Zhang S; Castro RA; Ianculescu AG; Yue L; Lo JC; Burchard EG; Brett CM; Giacomini KM
    J Clin Invest; 2007 May; 117(5):1422-31. PubMed ID: 17476361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renoprotective Effects of Metformin are Independent of Organic Cation Transporters 1 &2 and AMP-activated Protein Kinase in the Kidney.
    Christensen M; Jensen JB; Jakobsen S; Jessen N; Frøkiær J; Kemp BE; Marciszyn AL; Li H; Pastor-Soler NM; Hallows KR; Nørregaard R
    Sci Rep; 2016 Oct; 6():35952. PubMed ID: 27782167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of hepatic organic cation transporter 1 and hepatic distribution of metformin in high-fat diet-induced obese mice.
    Jang EH; Kim HK; Park CS; Kang JH
    Drug Metab Pharmacokinet; 2010; 25(4):392-7. PubMed ID: 20814161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OCT1 in hepatic steatosis and thiamine disposition.
    Chen L; Yee SW; Giacomini KM
    Cell Cycle; 2015; 14(3):283-4. PubMed ID: 25590948
    [No Abstract]   [Full Text] [Related]  

  • 8. Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3).
    Liang X; Chien HC; Yee SW; Giacomini MM; Chen EC; Piao M; Hao J; Twelves J; Lepist EI; Ray AS; Giacomini KM
    Mol Pharm; 2015 Dec; 12(12):4301-10. PubMed ID: 26528626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-administration of nuciferine reduces the concentration of metformin in liver via differential inhibition of hepatic drug transporter OCT1 and MATE1.
    Li L; Lei H; Wang W; Du W; Yuan J; Tu M; Zhou H; Zeng S; Jiang H
    Biopharm Drug Dispos; 2018 Nov; 39(9):411-419. PubMed ID: 30294927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics.
    Shu Y; Brown C; Castro RA; Shi RJ; Lin ET; Owen RP; Sheardown SA; Yue L; Burchard EG; Brett CM; Giacomini KM
    Clin Pharmacol Ther; 2008 Feb; 83(2):273-80. PubMed ID: 17609683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of Organic Cation Transporter 1 (OCT1) Substrates in Oct1/2 Knockout Mice and Species Difference in Hepatic OCT1-Mediated Uptake.
    Morse BL; Kolur A; Hudson LR; Hogan AT; Chen LH; Brackman RM; Sawada GA; Fallon JK; Smith PC; Hillgren KM
    Drug Metab Dispos; 2020 Feb; 48(2):93-105. PubMed ID: 31771949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.
    Nies AT; Koepsell H; Winter S; Burk O; Klein K; Kerb R; Zanger UM; Keppler D; Schwab M; Schaeffeler E
    Hepatology; 2009 Oct; 50(4):1227-40. PubMed ID: 19591196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability and Heritability of Thiamine Pharmacokinetics With Focus on OCT1 Effects on Membrane Transport and Pharmacokinetics in Humans.
    Jensen O; Matthaei J; Blome F; Schwab M; Tzvetkov MV; Brockmöller J
    Clin Pharmacol Ther; 2020 Mar; 107(3):628-638. PubMed ID: 31593619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin.
    Wang DS; Kusuhara H; Kato Y; Jonker JW; Schinkel AH; Sugiyama Y
    Mol Pharmacol; 2003 Apr; 63(4):844-8. PubMed ID: 12644585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin.
    Wang DS; Jonker JW; Kato Y; Kusuhara H; Schinkel AH; Sugiyama Y
    J Pharmacol Exp Ther; 2002 Aug; 302(2):510-5. PubMed ID: 12130709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response.
    Becker ML; Visser LE; van Schaik RH; Hofman A; Uitterlinden AG; Stricker BH
    Pharmacogenet Genomics; 2010 Jan; 20(1):38-44. PubMed ID: 19898263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions.
    Ahlin G; Chen L; Lazorova L; Chen Y; Ianculescu AG; Davis RL; Giacomini KM; Artursson P
    Pharmacogenomics J; 2011 Dec; 11(6):400-11. PubMed ID: 20567254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Clinical Importance of Hepatic Organic Cation Transporter 1 (OCT1) in Drug Pharmacokinetics, Dynamics, Pharmacogenetic Variability, and Drug Interactions.
    Zamek-Gliszczynski MJ; Giacomini KM; Zhang L
    Clin Pharmacol Ther; 2018 May; 103(5):758-760. PubMed ID: 29193038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants.
    Cho SK; Yoon JS; Lee MG; Lee DH; Lim LA; Park K; Park MS; Chung JY
    Clin Pharmacol Ther; 2011 Mar; 89(3):416-21. PubMed ID: 21270793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib.
    Ellawatty WEA; Masuo Y; Fujita KI; Yamazaki E; Ishida H; Arakawa H; Nakamichi N; Abdelwahed R; Sasaki Y; Kato Y
    Drug Metab Dispos; 2018 Jan; 46(1):33-40. PubMed ID: 29089306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.